Patent Monitoring

In 2023, nChain announced a partnership with Japan’s FinTeK (Keio University) to expedite the adoption of blockchain technology in the region. This collaboration showcases nChain’s strategy to [...]

With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have [...]

Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the [...]

The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these [...]

While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has [...]

The arthritis treatment industry is characterized by its intense competitiveness, driving companies to invest significantly in research and development to secure leading arthritis drug patents. [...]

More than 500 million people around the world are affected by diabetes, and this issue is intensified by a surging obesity crisis, particularly in wealthier nations. In such a crisis, drugs like [...]

The fiercely competitive nature of the oncology industry makes the companies invest heavily in research and development to bring in top cancer-treating drug patents. Consequently, the expiration [...]

Given the competitive nature of the pharmaceutical domain, the expiration of drug patents presents significant opportunities, particularly for companies specializing in generic medications.  [...]

A patent family is an unparalleled fortress, strategically safeguarding intellectual property across multiple jurisdictions. It forms a robust defense, enabling swift and global protection [...]

Have you considered that by solely performing competitor research based on their online presence and ranking, you miss many innovative companies working on similar technologies?  These [...]

The recent FDA controversy around Novo Nordisk’s Ozempic has brought many eyes to the drug.  For the uninitiated, Ozempic (semaglutide) is an anti-obesity medication for long-term weight [...]

Closely monitoring the patent expirations of well-known branded drugs, such as Abilify for schizophrenia and  Abaraxane for cancer treatment, is essential. This practice of monitoring [...]

If patents are your bread and butter, you know as much as I do that a thorough patent portfolio analysis is critical before deciding to buy them. However, the situation gets complicated by [...]

In 2020, the FDA approved loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis, Kala Pharmaceuticals Inc.) for treating dry eye disease. As one of the most common ocular surface disorders, [...]

Mergers and acquisitions have been a core business strategy for companies across almost all industries. A key reason for M&A deals today is the need to harness cutting-edge technologies [...]

Monitoring the drug exclusivity expiration timelines is just as important as patent expiration date when identifying opportunities and timing generic launches. Having access to detailed [...]

During the second quarter of 2023, there was a 7% increase in patent applications for immuno-oncology compared to the previous quarter, indicating a dynamic transformation in the oncology [...]

With companies filing for ANDAs, the global prescribed generics sales are expected to reach nearly 100 billion U.S. dollars by 2026. One example of this is Rexulti – a prescription [...]

European Patent (EP) has been a common patent valid across 39 contracting member states (27 EU countries and 12 other European countries). However, the downside of it has been that the [...]

The choice of patent databases highly depends on the motive beneath it, or in other words, the type of patent search involved. For instance, for a prior art search that is for current litigation, [...]

Are you familiar with Humira? The first fully lab-made immune protein approved by the US Food and Drug Administration (FDA) for various treatments.   In case you aren’t, Humira is a [...]

As the chip shortage lingers upon the world, TeleGrey, one of our clients from the telecommunications industry, approached us with a plan to get into chip development to become self-reliant. Just [...]

As innovation in self-driving technology is picking up the pace, acquiring the right patents can be crucial for IP managers to ensure their company stays ahead of the competition. But it isn’t as [...]

In 2019, OnePlus Technology faced a legal battle when EVS codec tech LLC & Saint Lawrence Communications- two U.S. NPEs sued this Chinese mobile giant for infringing on the patents related to [...]

Imagine you’re Mike, the IP Counsel of a leading technology manufacturing company. With the economy slowly slipping into a recession, you must ensure that your company doesn’t sink. This means [...]

If you are working in the food industry you might be witnessing the increasing competition and demand first hand. To maintain the edge, companies, including the industry giants, are encouragingly [...]

If Drug research and development is your bread and butter, you must be familiar with the wonders of Stelara.  For the uninitiated, Stelara is the brand name of the drug Ustekinumab, which is [...]

With the huge growth in the generic drug market, there is no doubt that generic companies (hey there!) are searching for drugs with a soon-to-be-expired label. With a new week comes a new list of [...]

Last week we uncovered the list of drug patents expiring in 2028. But can highfliers like you and I stop at that? Well, rest your numbing tendons for we’re here with the list of drug [...]

Our list of patents expiring from 2021 to 2025 was a blockbuster in the generic drug market. With the huge growth in the generic drug market, there is no doubt that generic companies (you too?) [...]

Last week we discussed the drug patents expiring in 2026. But that’s old news now. And as someone working in the generic drug market, you know how important it is to stay up to date. Right? [...]

Which drug patents are expiring in 2023? how about 2024? and 2025? There are about a dozen websites on the internet answering this very question. We can definitely do better than that. How about [...]

In the past, we published a list of drug patents expiring in 2023 and 2024. The list saw tremendous interest from people in the generic pharmaceutical industry.  And why not? With the explosive [...]

With the explosive growth in the generic drug market, generic companies (like yours) are in a battle to claim a share of the soon-to-be-expired drugs as quickly as possible. You would want to [...]

The article has a list of drug patents explored in 2023. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below. In 2020, we published an article [...]

This article lists drug patents from 2020 to 2022. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below. This article list has been updated on [...]

Biologics have been observed to be a rapidly evolving area within biotechnology. Cancer, autoimmune diseases, and diabetes treatments account for over 60% of the biologics market. Thus making it [...]

This assignment tracker helps you keep a track of recent assignment/reassignment activities happening in the US. The list provides the top 50 most recent patent assignments registered in the US [...]

“RoC has a rich history of skincare solutions innovation stemming from its French pharmacy roots. As the first brand to stabilize Retinol, which is one of the top U.S. [...]

Knowing the expiration date of a patent is important for multiple reasons; A key reason being that an expired patent goes into the public domain, which means everyone can now freely practice it. [...]

The Generic drugs industry is one of the fastest-growing industries of this century. Valued at USD 200 Billion in 2015, the global market for generic drugs is expected to reach USD 380 Billion by [...]

While much has been said about the need for a regular Competitor Patent Monitoring exercise in every major industry, the importance of the patent monitoring process in the Pharmaceutical [...]

Macitentan is a drug by Actelion for treating Pulmonary Arterial Hypertension (PAH). It’s popularly known as Opsumit and delays the progression of PAH, which got approval from the FDA in Dec [...]

How far have your closest competitors come? What patents? In what countries are they valid, and for how long? Or, more specifically: What has happened in your particular technological area during [...]